Asarfi Hospital shareholders approve NSE listing, BSE migration at AGM
- Shareholders approved migration from BSE SME Platform to BSE Main Board
- Listing of equity shares on the National Stock Exchange of India Limited was authorized
- Audited standalone and consolidated financial statements for FY26 were adopted
- Gopal Singh was re-appointed as Director after retiring by rotation
- The 21st AGM was held physically in Dhanbad with remote e-voting via NSDL

*this image is generated using AI for illustrative purposes only.
Asarfi Hospital Limited shareholders approved the company’s migration from the BSE SME Platform to the BSE Main Board and its listing on the National Stock Exchange of India Limited during its 21st Annual General Meeting.
The meeting was held on September 18, 2026, at the company’s registered office in Dhanbad, Jharkhand. Dr. Sukanti Kumar Das chaired the proceedings, which commenced at 12:00 pm and concluded at 2:00 pm.
Key Resolutions Passed
Shareholders approved three ordinary resolutions during the AGM:
- Adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.
- Re-appointment of Mr. Gopal Singh as Director, who retires by rotation and offered himself for re-election.
- Migration from the BSE SME Platform to the BSE Main Board and listing of equity shares on the National Stock Exchange of India Limited.
Attendance and Participation
A total of 16 members and six proxy or authorized representatives attended the physical meeting. The quorum was confirmed before the proceedings began.
The following directors and key managerial personnel were present:
| Name | Designation | Status |
|---|---|---|
| Udai Pratap Singh | Managing Director | Present |
| Madhuri Singh | Executive Director | Present |
| Dr. Sukanti Kumar Das | Non-Executive Director | Present |
| Gopal Singh | Director | Present |
| Rajkumari Sharma | Independent Director | Present |
| Harendra Singh | Chief Financial Officer | Present |
| Sudipa Singh | Company Secretary & Compliance Officer | Present |
Independent Director Amit Kumar Barnwal was absent from the meeting.
Voting Process
The company facilitated remote e-voting through NSDL from September 15, 2026, at 10:00 am to September 17, 2026, at 5:00 pm. CS Sourav Mall (Membership No. A67274) was appointed as the scrutinizer to oversee the voting process for both remote e-voting and physical voting at the AGM.
The Chairman addressed the members regarding future plans and growth projections, inviting queries from attendees. The statutory registers and other documents were available for inspection during the meeting.
Historical Stock Returns for Asarfi Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.13% | -10.23% | -25.27% | +18.36% | +29.42% | +72.16% |
How is the migration from the BSE SME Platform to the Main Board expected to impact Asarfi Hospital's stock liquidity and trading volume?
What specific growth projections or strategic initiatives did management highlight during the AGM regarding the company's expansion in Jharkhand?
Will the dual listing on NSE and BSE Main Board lead to changes in the company's corporate governance requirements or compliance costs?


































